News Detail

Mumbai, 23 Nov 2022: The Indian Pharmacopoeia Commission (IPC) has rejected Central Drugs Standard Control Organisation (CDSCO)’s request for extension of timelines to implement Indian Pharmacopoeia (IP) 2022.
Drugs Controller General of India (DCGI) Dr VG Somani......
View Details
Source : Pharmabiz
Indian Pharmacopoeia Commission
IPC
CDSCO
Indian Pharmacopoeia
IP 2022
DCGI
phytopharmaceutical ingredient
Related News
- Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)
- Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)
- SEC recommends permission for phase I trial of Cadila Pharma's VZV vaccine (22-09-2023)
- Adding preservatives to ayurvedic medicine will change the classification of medicine (22-09-2023)
- 50 children fell ill after taking filariasis medicine in Purnia (21-09-2023)
- Two smuggling gang youths arrested, one thousand intoxicating pills recovered (21-09-2023)
- FSDA Meerut team raided Transport Godown in Hapur to check consignment of Phensedyl (21-09-2023)
- NMC gets WFME Recognition for 10 Years (21-09-2023)
- Govt approved ₹480 crore to develop talent pool for medical devices sector (21-09-2023)
- DCGI approves nine more MDTLs taking total labs to test medical devices to 39 (21-09-2023)